Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000921895-25-000196·BIOTECHNOLOGY VALUE FUND L P
Schedule 13G ownership disclosure
ENGENE HOLDINGS INC
Common Shares, no par value per share · CUSIP: 29286M105
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BIOTECHNOLOGY VALUE FUND L P
Shares: 1,597,986.00 · Class: 3.1%
- BVF I GP LLC
Shares: 1,597,986.00 · Class: 3.1%
- BIOTECHNOLOGY VALUE FUND II LP
Shares: 1,263,389.00 · Class: 2.5%
- BVF II GP LLC
Shares: 1,263,389.00 · Class: 2.5%
- Biotechnology Value Trading Fund OS LP
Shares: 148,043.00 · Class: 0.3%
- BVF Partners OS Ltd.
Shares: 148,043.00 · Class: 0.3%
- BVF GP HOLDINGS LLC
Shares: 2,861,375.00 · Class: 5.5%
- BVF PARTNERS L P/IL
Shares: 3,051,439.00 · Class: 5.9%
- BVF INC/IL
Shares: 3,051,439.00 · Class: 5.9%
- LAMPERT MARK N
Shares: 3,051,439.00 · Class: 5.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-25-000196
- Form type
- SCHEDULE 13G/A
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Jan 29, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership